Skip to main content
SpringerLink
Log in

Environmental risk assessment of platinum cytotoxic drugs: a focus on toxicity characterization of hospital effluents

  • Original Paper
  • Published:
International Journal of Environmental Science and Technology Aims and scope Submit manuscript

A Correction to this article was published on 03 October 2017

This article has been updated

Abstract

Platinum-based cytotoxic drugs are complexes of Pt used in 50–70% of cancer patients. This study was performed during 2015, in two oncology wards of Qom hospitals in Iran. Sampling was carried out using effluent of the oncology wards for measurement of total Pt concentration. Analysis was performed by ICP–OES, and limit of detection was determined (LODs = 1 µg/L). During the sampling days, the total Pt concentration in the wastewater effluent oncology ward ranged from 5 to 762 µg/L at Shahid Beheshti Hospital and from 3 to 629 µg/L at Hazrat Masoumeh Hospital. According to the results from concentration of cytotoxic drugs, the predicted environmental concentrations (PECs) (ng/L) in wastewater treatment plant effluent and river for cisplatin, carboplatin and oxaliplatin were determined. Calculated RQhww showed that \(\sum {\text{RQ}}_{\text{hww}} = 1.19\). Thus, the total platinum compound drug could have potential toxicity effect on aquatic organisms. It was concluded that monitoring of cytotoxic drugs residue in hospital effluent must be considered because of their toxicity and impact on aquatic pollution. The results also revealed that PEC < 10 ng/L for all the platinum compound drugs and sum of the PEC calculation (\(\sum {\text{PEC}}_{{{\text{cis}},{\text{carbo}},{\text{oxali}}}}\)).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Change history

  • 03 October 2017

    The original version of this article unfortunately contained a mistake. The spelling of the Y. Ghafuri’s name was incorrect. The corrected name is given above.

References

  • Besse JP, Latour JF, Garric J (2012) Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs? Environ Int 39(1):73–86

    Article  CAS  Google Scholar 

  • Chen S, Chen B, Fath BD (2013) Ecological risk assessment on the system scale: a review of state-of-the-art models and future perspectives. Ecol Model 250:25–33

    Article  Google Scholar 

  • Daouk S, Chèvre N, Vernaz N, Widmer C, Daali Y,  Fleury-Souverain S (2016) Dynamics of active pharmaceutical ingredients loads in a Swiss university hospital wastewaters and prediction of the related environmental risk for the aquatic ecosystems. Sci Total Environ 547:244–253

    Article  CAS  Google Scholar 

  • EMEA EG (2006) CHMP. EWP workshop: slowing the progression of neurodegenerative diseases: medicinal products (MP) Clinical Development, London

  • Escher BI, Baumgartner R, Koller M, Treyer K, Lienert J, McArdell CS (2011) Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res 45(1):75–92

    Article  CAS  Google Scholar 

  • Ferrando-Climent L, Rodriguez-Mozaz S, Barceló D (2014) Incidence of anticancer drugs in an aquatic urban system: from hospital effluents through urban wastewater to natural environment. Environ Pollut 193:216–223

    Article  CAS  Google Scholar 

  • Franquet-Griell H, Gómez-Canela C, Ventura F, Lacorte S (2015) Predicting concentrations of cytostatic drugs in sewage effluents and surface waters of Catalonia (NE Spain). Environ Res 138:161–172

    Article  CAS  Google Scholar 

  • Frédéric O, Yves P (2014) Pharmaceuticals in hospital wastewater: their ecotoxicity and contribution to the environmental hazard of the effluent. Chemosphere 115:31–39

    Article  CAS  Google Scholar 

  • Fuerhacker M, Mahnik SN, Lenz K, Weissenbacher N, Mader RM, Krenn P, Ferk F (2007) Hospital waste water: health risk for human and environment by cytostatic drug emissions? Part I: model calculation and chemical monitoring. BMC Pharmacol 7(2):A69

    Article  Google Scholar 

  • Grung M, Källqvist T, Sakshaug S, Skurtveit S, Thomas KV (2008) Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicol Environ Saf 71(2):328–340

    Article  CAS  Google Scholar 

  • Hoseini M, Safari GH, Kamani H, Jaafari J, Ghanbarain M, Mahvi AH (2013) Sonocatalytic degradation of tetracycline antibiotic in aqueous solution by sonocatalysis. Toxicol Environ Chem 95(10):1680–1689

    Article  CAS  Google Scholar 

  • International Agency for Research on Cancer (1987) Overall evaluations of carcinogenicity: an updating of IARC monographs, vol 1 to 42. IARC, Lyon, p 53

    Google Scholar 

  • Jaafari J, Dehghani MH, Hoseini M, Safari GH (2015) Investigation of hospital solid waste management in Iran. World Rev Sci Technol Sustain Dev 12(2):111–125

    Article  Google Scholar 

  • Jaafari J, Seyedsalehi M, Safari G H, Ebrahimi Arjestan M, Barzanouni H, Ghadimi S, Haratipour P (2017) Simultaneous biological organic matter and nutrient removal in an anaerobic/anoxic/oxic (A2O) moving bed biofilm reactor (MBBR) integrated system. Int J Environ Sci Technol 14(2):291–304

    Article  CAS  Google Scholar 

  • Lenz K, Koellensperger G, Hann S, Weissenbacher N, Mahnik SN, Fuerhacker M (2007) Fate of cancerostatic platinum compounds in biological wastewater treatment of hospital effluents. Chemosphere 69(11):1765–1774

    Article  CAS  Google Scholar 

  • Negreira N, de Alda ML, Barceló D (2014) Cytostatic drugs and metabolites in municipal and hospital wastewaters in Spain: filtration, occurrence, and environmental risk. Sci Total Environ 497:68–77

    Article  CAS  Google Scholar 

  • Parrella A, Lavorgna M, Criscuolo E, Russo C, Isidori M (2014) Estrogenic activity and cytotoxicity of six anticancer drugs detected in water systems. Sci Total Environ 485:216–222

    Article  CAS  Google Scholar 

  • Rowney NC, Johnson AC, Williams RJ (2011) Erratum: Cytotoxic drugs in drinking water: a prediction and risk assessment exercise for the Thames catchment in the United Kingdom. Environ Toxicol Chem 30(7):1729–1729

    Article  Google Scholar 

  • Safari GH, Hoseini M, Seyedsalehi M, Kamani H, Jaafari J, Mahvi AH (2015) Photocatalytic degradation of tetracycline using nanosized titanium dioxide in aqueous solution. Int J Environ Sci Technol 12(2):603–616

    Article  CAS  Google Scholar 

  • Toolaram AP, Kümmerer K, Schneider M (2014) Environmental risk assessment of anti-cancer drugs and their transformation products: a focus on their genotoxicity characterization-state of knowledge and short comings. Mutat Res Rev Mutat Res 760:18–35

    Article  CAS  Google Scholar 

  • Vyas N, Turner A, Sewell G (2014) Platinum-based anticancer drugs in waste waters of a major UK hospital and predicted concentrations in recipient surface waters. Sci Total Environ 493:324–329

    Article  CAS  Google Scholar 

  • Zhang J, Chang VW, Giannis A, Wang JY (2013) Removal of cytostatic drugs from aquatic environment: a review. Sci Total Environ 445:281–298

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This project was supported by the Tehran University of Medical Sciences Health Services by Grant Number 95-02-103-32040.

Author information

Authors and Affiliations

  1. Department of Environmental Health Engineering, School of Public Health, International Campus, Tehran University of Medical Sciences (IC-TUMS), Tehran, Iran

    Y. Ghafuria & M. Alimohammadi

  2. Environmental Research Center, Qom University of Medical Science, Qom, Iran

    Y. Ghafuria

  3. Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

    M. Yunesian, R. Nabizadeh, A. Mesdaghinia & M. H. Dehghani

  4. Center for Air Pollution Research, Institute for Environmental Research, Tehran University of Medical Science, Tehran, Iran

    M. Yunesian

  5. Center for Water Quality Research, Institute for Environmental Research, Tehran University of Medical Science, Tehran, Iran

    M. Alimohammadi

Authors
  1. Y. Ghafuria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Yunesian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Nabizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Mesdaghinia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. H. Dehghani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Alimohammadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Alimohammadi.

Additional information

Editorial responsibility: B.V. Thomas.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghafuria, Y., Yunesian, M., Nabizadeh, R. et al. Environmental risk assessment of platinum cytotoxic drugs: a focus on toxicity characterization of hospital effluents. Int. J. Environ. Sci. Technol. 15, 1983–1990 (2018). https://doi.org/10.1007/s13762-017-1517-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13762-017-1517-6

Keywords

Search

Navigation